Skip to content

Galenicap: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Galenicap

BE 0782.712.794
NACE 21.100, Manufacture of basic pharmaceutical products and pharmaceutical preparations
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
-€533,037
2024 · -€248,670-€284,367
Equity
-€259,038
2024 · -€725,998+€466,960
Cash
€339,850
2024 · €45,237+€294,613
Balance sheet total
€1.5m
2024 · €699,121+€770,538

Largest movements

2024 to 2025
Assets
  • Receivables after one year +€452,480

    up €452,480 (+192%), from €235,838 to €688,318

  • Cash +€294,613

    up €294,613 (+651%), from €45,237 to €339,850

    mainly Contributions, distributions and other (+€999,996) and Debts after one year (+€317,763)

  • Receivables within one year +€36,545

    up €36,545 (+317%), from €11,528 to €48,073

    of which Trade receivables: +€19,932

  • Intangible fixed assets -€16,864

    down €16,864 (-4.2%), from €403,842 to €386,979

Equity and liabilities
  • Contributions +€999,996

    up €999,996 (+100,000%), from €1,000 to €1.0m

  • Profit (loss) carried forward -€533,037

    down €533,037 (-73.3%), from -€726,998 to -€1.3m

  • Debts after one year +€317,763

    up €317,763 (+24.1%), from €1.3m to €1.6m

Income statement
  • Gross operating margin -€279,050

    down €279,050 (-186%), from -€150,290 to -€429,341

  • Financial charges +€26,213

    up €26,213 (+50.8%), from €51,626 to €77,839

  • Taxes -€17,374

    new in 2025: -€17,374

  • Financial income +€10,044

    up €10,044 (+75.5%), from €13,302 to €23,347

  • Depreciation +€6,521

    up €6,521 (+10.9%), from €59,656 to €66,177

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€248,670
Gross operating margin -€279,050
Depreciation -€6,521
Other operating charges +€0
Financial income +€10,044
Financial charges -€26,213
Taxes +€17,374
Result 2025 -€533,037
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€972,333
Investment -€50,813
Financing +€1.3m
Cash 2024 €45,237
Net result for the year -€533,037
Depreciation +€66,177
Receivables after one year -€452,480
Receivables within one year -€36,545
Deferred charges and accrued income -€2,264
Trade debts -€8,704
Tax, wage and social debts +€4,855
Accrued charges and deferred income -€10,335
Investment in fixed assets (net) -€50,813
Debts after one year +€317,763
Contributions, distributions and other +€999,996
Cash 2025 €339,850
brings cash intakes cash out
Every line side by side 37 lines
Line Code 2024 2025 Change %
Total assets 20/58 €699,121 €1,469,659 +€770,538 +110%
Fixed assets 21/28 €404,842 €389,479 -€15,364 -3.8%
Intangible fixed assets 21 €403,842 €386,979 -€16,864 -4.2%
Financial fixed assets 28 €1,000 €2,500 +€1,500 +150%
Current assets 29/58 €294,278 €1,080,180 +€785,902 +267%
Amounts receivable after more than one year 29 €235,838 €688,318 +€452,480 +192%
Other amounts receivable 291 €235,838 €688,318 +€452,480 +192%
Amounts receivable within one year 40/41 €11,528 €48,073 +€36,545 +317%
Trade receivables 40 €211 €20,143 +€19,932 +9,447%
Other amounts receivable 41 €11,317 €27,930 +€16,613 +147%
Cash at bank and in hand 54/58 €45,237 €339,850 +€294,613 +651%
Deferred charges and accrued income 490/1 €1,675 €3,939 +€2,264 +135%
Total equity and liabilities 10/49 €699,121 €1,469,659 +€770,538 +110%
Equity 10/15 -€725,998 -€259,038 +€466,960 +64.3%
Contributions 10/11 €1,000 €1,000,996 +€999,996 +100,000%
Profit (loss) carried forward 14 -€726,998 -€1,260,034 -€533,037 -73.3%
Amounts payable 17/49 €1,425,118 €1,728,697 +€303,578 +21.3%
Amounts payable after more than one year 17 €1,317,563 €1,635,325 +€317,763 +24.1%
Financial debts 170/4 €1,317,563 €1,635,325 +€317,763 +24.1%
Amounts payable within one year 42/48 €93,756 €89,906 -€3,850 -4.1%
Trade debts 44 €93,756 €85,051 -€8,704 -9.3%
Suppliers 440/4 €93,756 €85,051 -€8,704 -9.3%
Taxes, remuneration and social security 45 - €4,855 +€4,855
Taxes 450/3 - €4,855 +€4,855
Accrued charges and deferred income 492/3 €13,800 €3,465 -€10,335 -74.9%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €59,656 €66,177 +€6,521 +10.9%
Other operating charges 640/8 €400 €400 -€0 -0.1%
Gross operating margin 9900 -€150,290 -€429,341 -€279,050 -186%
Operating profit (loss) 9901 -€210,347 -€495,918 -€285,571 -136%
Financial income 75/76B €13,302 €23,347 +€10,044 +75.5%
Recurring financial income 75 €13,302 €23,347 +€10,044 +75.5%
Financial charges 65/66B €51,626 €77,839 +€26,213 +50.8%
Recurring financial charges 65 €51,626 €77,839 +€26,213 +50.8%
Profit (loss) for the period before taxes 9903 -€248,670 -€550,410 -€301,740 -121%
Income taxes 67/77 - -€17,374 -€17,374
Profit (loss) for the period 9904 -€248,670 -€533,037 -€284,367 -114%
Profit (loss) for the period to be appropriated 9905 -€248,670 -€533,037 -€284,367 -114%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 19 October 2026 via checked.be.